Yesterday another pediatric voucher was sold for 105M USD (about average) only a month after the approval of the drug that was entitled to it, this is a sign that there is always someone interested in acquiring it, Acadia has now been available for 14 months he has the Daybue voucher (a record), he doesn't use it and he doesn't sell it, why? Will he need it for some molecules in the future? Or don't you want to come up with 1/3 of the cash to give to Neuren right now?
https://investors.x4pharma.com/news...ls-announces-125-million-capital-infusion-105
Acadia, page-536
-
- There are more pages in this discussion • 148 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.17 |
Change
0.070(0.35%) |
Mkt cap ! $2.578B | |||
| Open | High | Low | Value | Volume |
| $20.39 | $20.53 | $20.14 | $4.102M | 202.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 249 | $20.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.31 | 790 | 1 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |